Runny nose is the most common disease of the upper respiratory tract. This pathology is provoked by various factors: viral and bacterial infections, hypothermia, the effects of chemical reagents and allergic stimuli, etc. Recently, cases of allergic seasonal and year-round rhinitis, characterized by symptoms such as pruritus in the nose, abundant mucus secretion, sneezing, difficulty in nasal breathing, are quite often noted.
One of the most effective remedies, which are prescribed in such cases, are intranasal glucocorticoids, among which are preparations Desrinitis and Nazonex. These are quite potent hormonal medicines, which, however, with local administration to the nasal cavity, do not affect systemically and rarely cause unwanted reactions. Many patients are interested in what is better - Desrinitis or Nazonex, tk. they are often prescribed by both doctors, suggesting to take one of them that will be in the pharmacy.
Composition of Nazonex and Desrinitis
In fact, Nazonex and Desrinitis are analogous, because based on the same active substance - mometasone furoate in the form of monohydrate, which is contained in both preparations in the same amount. Minor differences exist in the list of excipients of drugs, but this does not affect their effectiveness.
Having a similar composition, both Nazonex and Desirinite are presented in the form of a spray, i.e. have the same form of output. Vials of preparations are equipped with a convenient dosing device that provides full coverage of the nasal mucosa and uniform distribution of the drug.
Pharmacological action and indications of Nazonex and Desrinitis
The active substance of both drugs - mometasone furoate - is a synthetic new-generation glucocorticoid that has a powerful anti-inflammatory, anti-allergic, antipruritic and vasoconstrictive effect in local use. These drugs are prescribed in such cases:
- seasonal and year-round runny allergic etiology (for treatment and prevention);
- sinusitis in acute stage or exacerbation of chronic sinusitis (as part of complex therapy in parallel with antibiotics);
- uncomplicated acute rhinosinusitis;
- polyposis of nose, characterized by impaired breathing and lack of smell.
If there are appropriate indications, accurate compliance with the regimens, these drugs can be used for a long time. It is worth emphasizing once again that Nazonex and Desrinitis do not exert systemic influence (due to low bioavailability of mometasone furoate). In addition, according to studies of the drug Nazonex, mometasone furoate does not reduce immunity, but, conversely, reduces the risk of colds and viral respiratory diseases in patients.
What is cheaper - Nazonex or Desinitis?
Given that the sprains of Nazonex and Desinitis are complete analogs, for most patients an important factor in choosing one of the tools will be the price position. Nazonex is produced by a Belgian pharmaceutical company and is an original preparation protected by a patent. Therefore, its cost is far from low. Desrinitis can be called a drug-copy, produced in the Czech Republic, in connection with which its price is much lower than the original. Therefore, Desinitis can become a drug of choice in the narrow material possibilities of the patient, while the effectiveness of therapy with this drug will be at the same level as with treatment with Nazonex.